PHASE 2 TRIAL: EVALUATION OF SILYMARIN FOR TREATMENT OF PATIENTS WITH COVID-19

Authors
Category Primary study
Registry of TrialsPan African Clinical Trials Registry
Year 2021
INTERVENTION: Chloroquine Silymarin based combination CONDITION: ; COVID 19 COVID 19 PRIMARY OUTCOME: Clinical recovery from start of treatment SECONDARY OUTCOME: Safety and tolerability: Viral clearance (SARS COV 2 RT‐PCR) INCLUSION CRITERIA: 1. Positive SARS COV‐2 RT‐PCR 2. Age > 6 weeks and above 2. Had not received any of the study drugs for at least one day
Epistemonikos ID: cb9ad5bbe5c7525697eb8713f5dda282b3d19747
First added on: Feb 19, 2021